Up­dat­ed: Te­va picks for­mer San­doz head as new CEO to re­place Kåre Schultz

Te­va has tapped the for­mer CEO of San­doz, Richard Fran­cis, to lead the Is­raeli gener­ics gi­ant, re­plac­ing cur­rent CEO Kåre Schultz.

Fran­cis led San­doz, the gener­ics di­vi­sion of No­var­tis, for five years from 2014 to 2019, leav­ing as No­var­tis be­gan mak­ing plans to spin out the unit. It’s been a chal­leng­ing sev­er­al years for gener­ics com­pa­nies, which have seen sup­ply chains dis­rupt­ed, pres­sure on how much they can charge for drugs, and stock prices in de­cline.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER